Anders Edsjö
Lund University · 104 works · 2,694 citations · h-index 29
Top works
- Guidance for laboratories performing molecular pathology for cancer patients
- External Quality Assessment for KRAS Testing Is Needed: Setup of a European Program and Report of the First Joined Regional Quality Assessment Rounds
- Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
- miR‐34c is downregulated in prostate cancer and exerts tumor suppressive functions
- Guideline on the requirements of external quality assessment programs in molecular pathology
- Preparation of DNA from cytological material
- Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBL
- European Consensus Conference for external quality assessment in molecular pathology
- Neuroblastoma as an experimental model for neuronal differentiation and hypoxia-induced tumor cell dedifferentiation
- Implementation of precision medicine in healthcare—A European perspective
- Expression of trkB in Human Neuroblastoma in Relation to MYCN Expression and Retinoic Acid Treatment
- miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients
- Upregulation of miR-96 Enhances Cellular Proliferation of Prostate Cancer Cells through FOXO1
- miQ—A novel microRNA based diagnostic and prognostic tool for prostate cancer
- Prognostic stromal gene signatures in breast cancer
- The expression pattern of matrix-producing tumor stroma is of prognostic importance in breast cancer
- Trailblazing precision medicine in Europe: A joint view by Genomic Medicine Sweden and the Centers for Personalized Medicine, ZPM, in Germany
- ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value
- Neuroblastoma cells with overexpressed MYCN retain their capacity to undergo neuronal differentiation
- Precision cancer medicine: Concepts, current practice, and future developments